Cigna-Express Scripts Deal Gets the Green Light

Cigna’s acquisition of Express Scripts was approved by federal officials
By Katie King Posted on September 20, 2018

Cigna’s $67 billion acquisition of pharmacy benefits manager (PBM), Express Scripts, was approved by federal officials this week.

The Council Perspective: Express Scripts is one of the last standalone PBMs. This, and other pending mergers like CVS Health and Aetna, signals a desire to lower costs and prevent any disturbance from startups and new industry players, like the recent Amazon Berkshire Hathaway JP Morgan venture. At the same time, PBMs have been criticized for their role in negotiating drug prices, leaving many questioning if mergers like this will help or hinder efforts to align incentives throughout the drug supply chain to reduce costs for end payers. To succeed, the new Cigna-Express Scripts will mostly likely need to think about its PBM arm as a value-focused component of its insurance business.

Katie King Vice President, Health Policy & Strategy, The Council Read More

More in Health+Benefits

Canadian Health Benefits Evolve with U.S. Flavor
Health+Benefits Canadian Health Benefits Evolve with U.S. Flavor
Group health plans can lure and retain employees unhappy with government healthc...
Health+Benefits More Employers Use ICHRAs to Save Health Dollars
Q&A with Victoria Hodgkins, CEO of PeopleKeep
Opening Up on Obesity
Health+Benefits Opening Up on Obesity
Formal recognition of the disease can now position employers to address this co...